Overview

SOLIACS: Solian Solution in the Acute Setting

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
During this study the efficacy and safety profile will be evaluated of the use of amisulpride in the form of a solution in schizophrenic patients with an acute episode. The main purpose of the study is to observe the anti-psychotic effect of amisulpride as a solution during the first days of an acute episode of schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Amisulpride
Sultopride